Expert Review of Pharmacoeconomics & Outcomes Research

Scope & Guideline

Shaping the Future of Healthcare with Evidence-Based Insights

Introduction

Immerse yourself in the scholarly insights of Expert Review of Pharmacoeconomics & Outcomes Research with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1473-7167
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2001 to 2024
AbbreviationEXPERT REV PHARM OUT / Expert Rev. Pharmacoecon. Outcomes Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The Expert Review of Pharmacoeconomics & Outcomes Research focuses on the critical evaluation of pharmacoeconomic studies and their implications for healthcare outcomes. Its scope encompasses a wide range of topics related to health economics, cost-effectiveness analysis, and the impact of healthcare interventions on patient outcomes.
  1. Pharmacoeconomics:
    The journal publishes comprehensive analyses of the economic aspects of drug therapies, including cost-effectiveness and budget impact analyses, to inform healthcare decision-making.
  2. Health Technology Assessment (HTA):
    Research on the methodologies and applications of HTA in evaluating the value of new health technologies, drugs, and interventions to guide policy and reimbursement decisions.
  3. Patient-reported Outcomes:
    Studies focusing on measuring and valuing health-related quality of life and patient-reported outcomes, which are critical for assessing the impact of treatments from the patient's perspective.
  4. Comparative Effectiveness Research:
    Analysis comparing the effectiveness, safety, and cost of different therapeutic interventions to provide evidence for clinical guidelines and policy-making.
  5. Digital Health and Innovation:
    Exploration of the economic implications of digital health technologies and innovations, including their role in improving medication adherence and patient outcomes.
  6. Global Health Economics:
    Research addressing pharmacoeconomic evaluations in various global contexts, particularly in low- and middle-income countries, to understand the broader implications of healthcare interventions.
The journal has seen a rise in interest in several emerging themes that align with contemporary challenges in pharmacoeconomics and healthcare delivery.
  1. Integration of Machine Learning and AI:
    There is a growing trend towards utilizing machine learning and artificial intelligence in health economic evaluations, offering novel approaches to predict outcomes and enhance decision-making.
  2. Value-Based Healthcare Models:
    An increased focus on value-based healthcare, with research exploring how to align reimbursement models with patient outcomes and overall healthcare value.
  3. Real-World Evidence (RWE):
    The importance of real-world evidence is gaining traction, with studies emphasizing the need to assess the effectiveness and economic impact of interventions in everyday clinical settings.
  4. Patient Engagement in Research:
    Emerging themes include the engagement of patients in the development of health economic evaluations, emphasizing the importance of incorporating patient preferences and experiences.
  5. Sustainability and Environmental Considerations:
    A new focus on incorporating sustainability metrics into health economic evaluations, addressing the environmental impact of healthcare interventions.
  6. Cross-Disciplinary Approaches:
    An increase in interdisciplinary research that combines insights from economics, public health, and clinical practice to address complex healthcare challenges.

Declining or Waning

While the journal has maintained a robust focus on pharmacoeconomics and health outcomes, certain themes appear to be waning in prominence based on recent publications.
  1. Traditional Cost-Utility Analyses:
    There is a noticeable decline in studies solely relying on traditional cost-utility analyses without integrating broader health economic perspectives or real-world evidence.
  2. Focus on Localized Studies:
    The emphasis on localized pharmacoeconomic studies is decreasing, with a shift towards more globally relevant research that can inform international health policies.
  3. Single Disease Focus:
    Research concentrating on singular diseases is becoming less common, as the journal increasingly favors studies that incorporate multi-condition perspectives or address comorbidities.
  4. Outdated Methodologies:
    There is a decline in the publication of studies utilizing outdated economic evaluation methodologies, as the field evolves towards more sophisticated and innovative approaches.
  5. Static Policy Evaluations:
    Research that merely evaluates existing policies without proposing actionable insights or innovations is becoming less prevalent, reflecting a need for more dynamic and forward-thinking analyses.

Similar Journals

European Journal of Health Economics

Empowering Research in Health Economics and Policy
Publisher: SPRINGERISSN: 1618-7598Frequency: 4 issues/year

The European Journal of Health Economics, published by SPRINGER, is a premier interdisciplinary journal dedicated to advancing research in the intersection of health policy and economic theory. With an impressive impact factor and consistently ranked in the Q1 category in both Economics and Health Policy (2023), this journal serves as a vital platform for disseminating innovative research findings and practical insights relevant to today's healthcare challenges. Covering a broad spectrum of topics, from health care financing and economic evaluation to policy analysis, the journal aims to foster dialogue among academics, policymakers, and practitioners alike. Published continuously from 2002 to 2024, the European Journal of Health Economics holds its rank within the top 12% of Economics and Finance journals and the top 16% in Medicine. Researchers and students looking to stay abreast of the latest trends and methodologies in health economics will find this journal an invaluable resource.

Research in Social & Administrative Pharmacy

Elevating pharmacy practice through rigorous academic exploration.
Publisher: ELSEVIER SCIENCE INCISSN: 1551-7411Frequency: 12 issues/year

Research in Social & Administrative Pharmacy, published by Elsevier Science Inc, is a premier academic journal that plays a pivotal role in shaping the field of pharmaceutical sciences and pharmacy practice. With an impressive impact factor and ranked in the Q1 category for both Pharmaceutical Science and Pharmacy, this journal is dedicated to the dissemination of cutting-edge research from 2005 to 2024. Targeting a diverse audience of researchers, professionals, and students, the journal covers a broad spectrum of topics including social pharmacy, policy, and administrative aspects of pharmacy practice, contributing to advancements in healthcare. As an essential resource for those engaging in pharmaceutical research, the journal upholds rigorous peer-review standards and ensures wide accessibility to influential studies that address contemporary issues in pharmacy and healthcare administration, making it an invaluable tool for knowledge enhancement and practical applications.

VALUE IN HEALTH

Exploring the Intersection of Health Policy and Practice
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

Value in Health Regional Issues

Transforming Healthcare Economics Through Regional Analysis.
Publisher: ELSEVIERISSN: 2212-1099Frequency: 3 issues/year

Value in Health Regional Issues, published by Elsevier, is an essential academic journal that addresses critical developments in the field of health economics, policy, and pharmaceuticals. With an impressive impact factor, this journal has established itself as a leading platform for disseminating innovative research, evidenced by its Q1 quartile ranking in Economics, Econometrics and Finance and Pharmacology, Toxicology and Pharmaceutics. Founded in 2012, the journal is dedicated to exploring value-based healthcare, focusing on regional perspectives that highlight economic implications and health outcomes. Covering a convergence of multidisciplinary themes, the journal fosters academic collaboration and provides researchers, professionals, and students with access to high-quality, peer-reviewed articles. As it continues to expand its scope through 2025, Value in Health Regional Issues remains a pivotal resource for those seeking to understand and influence health policy and economic frameworks on a regional, national, and global scale.

Cost Effectiveness and Resource Allocation

Empowering Decisions for Effective Resource Allocation
Publisher: BMCISSN: 1478-7547Frequency: 1 issue/year

Cost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.

MEDICAL DECISION MAKING

Advancing health policy through rigorous research.
Publisher: SAGE PUBLICATIONS INCISSN: 0272-989XFrequency: 8 issues/year

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

HEALTH TECHNOLOGY ASSESSMENT

Advancing the future of healthcare through rigorous technology assessment.
Publisher: NIHR JOURNALS LIBRARYISSN: 1366-5278Frequency:

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

Health Economics Review

Empowering decision-makers with robust economic evaluations.
Publisher: BMCISSN: 2191-1991Frequency: 1 issue/year

Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.

AMERICAN JOURNAL OF MANAGED CARE

Navigating the complexities of healthcare management together.
Publisher: MANAGED CARE & HEALTHCARE COMMUNICATIONS LLCISSN: 1088-0224Frequency: 12 issues/year

AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.

International Journal of Health Economics and Management

Elevating healthcare management through rigorous economic research.
Publisher: SPRINGERISSN: 2199-9023Frequency: 4 issues/year

International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.